nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CHRM3—ureter—colon cancer	0.0664	0.35	CbGeAlD
Cevimeline—CHRM3—muscle of abdomen—colon cancer	0.0478	0.252	CbGeAlD
Cevimeline—FMO1—renal system—colon cancer	0.0128	0.0677	CbGeAlD
Cevimeline—FMO1—digestive system—colon cancer	0.0105	0.0555	CbGeAlD
Cevimeline—FMO1—vagina—colon cancer	0.0093	0.049	CbGeAlD
Cevimeline—FMO1—liver—colon cancer	0.00785	0.0414	CbGeAlD
Cevimeline—FMO1—lymph node—colon cancer	0.00602	0.0317	CbGeAlD
Cevimeline—CHRM3—smooth muscle tissue—colon cancer	0.00548	0.0289	CbGeAlD
Cevimeline—CHRM3—renal system—colon cancer	0.00528	0.0278	CbGeAlD
Cevimeline—CHRM3—digestive system—colon cancer	0.00433	0.0228	CbGeAlD
Cevimeline—CYP3A4—renal system—colon cancer	0.0029	0.0153	CbGeAlD
Cevimeline—CYP2D6—renal system—colon cancer	0.00285	0.015	CbGeAlD
Cevimeline—CYP3A4—digestive system—colon cancer	0.00238	0.0125	CbGeAlD
Cevimeline—CYP2D6—digestive system—colon cancer	0.00234	0.0123	CbGeAlD
Cevimeline—CYP3A4—liver—colon cancer	0.00177	0.00934	CbGeAlD
Cevimeline—CYP2D6—liver—colon cancer	0.00174	0.00919	CbGeAlD
Cevimeline—Cough—Irinotecan—colon cancer	0.00092	0.00113	CcSEcCtD
Cevimeline—Weight decreased—Capecitabine—colon cancer	0.000916	0.00113	CcSEcCtD
Cevimeline—Hyperglycaemia—Capecitabine—colon cancer	0.000913	0.00113	CcSEcCtD
Cevimeline—Hypertension—Irinotecan—colon cancer	0.00091	0.00112	CcSEcCtD
Cevimeline—Pneumonia—Capecitabine—colon cancer	0.000908	0.00112	CcSEcCtD
Cevimeline—Leukopenia—Fluorouracil—colon cancer	0.000903	0.00112	CcSEcCtD
Cevimeline—Depression—Capecitabine—colon cancer	0.0009	0.00111	CcSEcCtD
Cevimeline—Acute coronary syndrome—Capecitabine—colon cancer	0.00089	0.0011	CcSEcCtD
Cevimeline—Discomfort—Irinotecan—colon cancer	0.000886	0.00109	CcSEcCtD
Cevimeline—Neuropathy peripheral—Capecitabine—colon cancer	0.000885	0.00109	CcSEcCtD
Cevimeline—Myocardial infarction—Capecitabine—colon cancer	0.000885	0.00109	CcSEcCtD
Cevimeline—Oedema—Vincristine—colon cancer	0.000883	0.00109	CcSEcCtD
Cevimeline—Stomatitis—Capecitabine—colon cancer	0.00088	0.00109	CcSEcCtD
Cevimeline—Infection—Vincristine—colon cancer	0.000877	0.00108	CcSEcCtD
Cevimeline—Conjunctivitis—Capecitabine—colon cancer	0.000877	0.00108	CcSEcCtD
Cevimeline—Urinary tract infection—Capecitabine—colon cancer	0.000877	0.00108	CcSEcCtD
Cevimeline—Convulsion—Fluorouracil—colon cancer	0.000875	0.00108	CcSEcCtD
Cevimeline—Osteoarthritis—Methotrexate—colon cancer	0.000872	0.00108	CcSEcCtD
Cevimeline—Confusional state—Irinotecan—colon cancer	0.000867	0.00107	CcSEcCtD
Cevimeline—Nervous system disorder—Vincristine—colon cancer	0.000866	0.00107	CcSEcCtD
Cevimeline—Thrombocytopenia—Vincristine—colon cancer	0.000865	0.00107	CcSEcCtD
Cevimeline—Haematuria—Capecitabine—colon cancer	0.000861	0.00106	CcSEcCtD
Cevimeline—Oedema—Irinotecan—colon cancer	0.00086	0.00106	CcSEcCtD
Cevimeline—Chest pain—Fluorouracil—colon cancer	0.000859	0.00106	CcSEcCtD
Cevimeline—Myalgia—Fluorouracil—colon cancer	0.000859	0.00106	CcSEcCtD
Cevimeline—Infection—Irinotecan—colon cancer	0.000854	0.00105	CcSEcCtD
Cevimeline—Hyperhidrosis—Vincristine—colon cancer	0.000854	0.00105	CcSEcCtD
Cevimeline—Epistaxis—Capecitabine—colon cancer	0.000851	0.00105	CcSEcCtD
Cevimeline—Discomfort—Fluorouracil—colon cancer	0.000849	0.00105	CcSEcCtD
Cevimeline—Shock—Irinotecan—colon cancer	0.000846	0.00104	CcSEcCtD
Cevimeline—Nervous system disorder—Irinotecan—colon cancer	0.000843	0.00104	CcSEcCtD
Cevimeline—Agranulocytosis—Capecitabine—colon cancer	0.000842	0.00104	CcSEcCtD
Cevimeline—Thrombocytopenia—Irinotecan—colon cancer	0.000842	0.00104	CcSEcCtD
Cevimeline—Anorexia—Vincristine—colon cancer	0.000842	0.00104	CcSEcCtD
Cevimeline—Hyperhidrosis—Irinotecan—colon cancer	0.000831	0.00103	CcSEcCtD
Cevimeline—Confusional state—Fluorouracil—colon cancer	0.000831	0.00103	CcSEcCtD
Cevimeline—Mood swings—Methotrexate—colon cancer	0.000826	0.00102	CcSEcCtD
Cevimeline—Hypotension—Vincristine—colon cancer	0.000825	0.00102	CcSEcCtD
Cevimeline—Oedema—Fluorouracil—colon cancer	0.000824	0.00102	CcSEcCtD
Cevimeline—Anorexia—Irinotecan—colon cancer	0.00082	0.00101	CcSEcCtD
Cevimeline—Infection—Fluorouracil—colon cancer	0.000818	0.00101	CcSEcCtD
Cevimeline—Haemoglobin—Capecitabine—colon cancer	0.000814	0.00101	CcSEcCtD
Cevimeline—Rhinitis—Capecitabine—colon cancer	0.000812	0.001	CcSEcCtD
Cevimeline—Haemorrhage—Capecitabine—colon cancer	0.00081	0.001	CcSEcCtD
Cevimeline—Nervous system disorder—Fluorouracil—colon cancer	0.000808	0.000997	CcSEcCtD
Cevimeline—Thrombocytopenia—Fluorouracil—colon cancer	0.000807	0.000995	CcSEcCtD
Cevimeline—Hypoaesthesia—Capecitabine—colon cancer	0.000806	0.000995	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Vincristine—colon cancer	0.000805	0.000993	CcSEcCtD
Cevimeline—Pharyngitis—Capecitabine—colon cancer	0.000804	0.000992	CcSEcCtD
Cevimeline—Tachycardia—Fluorouracil—colon cancer	0.000804	0.000992	CcSEcCtD
Cevimeline—Hypotension—Irinotecan—colon cancer	0.000804	0.000992	CcSEcCtD
Cevimeline—Insomnia—Vincristine—colon cancer	0.000799	0.000986	CcSEcCtD
Cevimeline—Oedema peripheral—Capecitabine—colon cancer	0.000798	0.000985	CcSEcCtD
Cevimeline—Urethral disorder—Capecitabine—colon cancer	0.000794	0.00098	CcSEcCtD
Cevimeline—Paraesthesia—Vincristine—colon cancer	0.000793	0.000979	CcSEcCtD
Cevimeline—Anorexia—Fluorouracil—colon cancer	0.000785	0.000969	CcSEcCtD
Cevimeline—Visual impairment—Capecitabine—colon cancer	0.000781	0.000964	CcSEcCtD
Cevimeline—Insomnia—Irinotecan—colon cancer	0.000778	0.00096	CcSEcCtD
Cevimeline—Paraesthesia—Irinotecan—colon cancer	0.000772	0.000953	CcSEcCtD
Cevimeline—Hypotension—Fluorouracil—colon cancer	0.00077	0.00095	CcSEcCtD
Cevimeline—Decreased appetite—Vincristine—colon cancer	0.000768	0.000948	CcSEcCtD
Cevimeline—Dyspnoea—Irinotecan—colon cancer	0.000767	0.000946	CcSEcCtD
Cevimeline—Somnolence—Irinotecan—colon cancer	0.000765	0.000944	CcSEcCtD
Cevimeline—Fatigue—Vincristine—colon cancer	0.000761	0.00094	CcSEcCtD
Cevimeline—Eye disorder—Capecitabine—colon cancer	0.000757	0.000935	CcSEcCtD
Cevimeline—Dyspepsia—Irinotecan—colon cancer	0.000757	0.000934	CcSEcCtD
Cevimeline—Tinnitus—Capecitabine—colon cancer	0.000755	0.000932	CcSEcCtD
Cevimeline—Pain—Vincristine—colon cancer	0.000755	0.000932	CcSEcCtD
Cevimeline—Constipation—Vincristine—colon cancer	0.000755	0.000932	CcSEcCtD
Cevimeline—Asthma—Methotrexate—colon cancer	0.000754	0.00093	CcSEcCtD
Cevimeline—Cardiac disorder—Capecitabine—colon cancer	0.000752	0.000928	CcSEcCtD
Cevimeline—Flushing—Capecitabine—colon cancer	0.000752	0.000928	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000751	0.000926	CcSEcCtD
Cevimeline—Decreased appetite—Irinotecan—colon cancer	0.000748	0.000923	CcSEcCtD
Cevimeline—Eosinophilia—Methotrexate—colon cancer	0.000746	0.000921	CcSEcCtD
Cevimeline—Insomnia—Fluorouracil—colon cancer	0.000745	0.00092	CcSEcCtD
Cevimeline—Fatigue—Irinotecan—colon cancer	0.000742	0.000915	CcSEcCtD
Cevimeline—Paraesthesia—Fluorouracil—colon cancer	0.00074	0.000913	CcSEcCtD
Cevimeline—Pain—Irinotecan—colon cancer	0.000736	0.000908	CcSEcCtD
Cevimeline—Constipation—Irinotecan—colon cancer	0.000736	0.000908	CcSEcCtD
Cevimeline—Angiopathy—Capecitabine—colon cancer	0.000735	0.000907	CcSEcCtD
Cevimeline—Dyspnoea—Fluorouracil—colon cancer	0.000734	0.000906	CcSEcCtD
Cevimeline—Somnolence—Fluorouracil—colon cancer	0.000732	0.000904	CcSEcCtD
Cevimeline—Chills—Capecitabine—colon cancer	0.000727	0.000897	CcSEcCtD
Cevimeline—Dyspepsia—Fluorouracil—colon cancer	0.000725	0.000895	CcSEcCtD
Cevimeline—Arrhythmia—Capecitabine—colon cancer	0.000724	0.000893	CcSEcCtD
Cevimeline—Gastrointestinal pain—Vincristine—colon cancer	0.000722	0.000891	CcSEcCtD
Cevimeline—Decreased appetite—Fluorouracil—colon cancer	0.000716	0.000884	CcSEcCtD
Cevimeline—Alopecia—Capecitabine—colon cancer	0.000716	0.000884	CcSEcCtD
Cevimeline—Feeling abnormal—Irinotecan—colon cancer	0.000709	0.000875	CcSEcCtD
Cevimeline—Malnutrition—Capecitabine—colon cancer	0.000705	0.000871	CcSEcCtD
Cevimeline—Dysuria—Methotrexate—colon cancer	0.000705	0.00087	CcSEcCtD
Cevimeline—Pain—Fluorouracil—colon cancer	0.000704	0.000869	CcSEcCtD
Cevimeline—Gastrointestinal pain—Irinotecan—colon cancer	0.000703	0.000868	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Methotrexate—colon cancer	0.0007	0.000864	CcSEcCtD
Cevimeline—Abdominal pain—Vincristine—colon cancer	0.000698	0.000862	CcSEcCtD
Cevimeline—Body temperature increased—Vincristine—colon cancer	0.000698	0.000862	CcSEcCtD
Cevimeline—Flatulence—Capecitabine—colon cancer	0.000695	0.000858	CcSEcCtD
Cevimeline—Erectile dysfunction—Methotrexate—colon cancer	0.000694	0.000857	CcSEcCtD
Cevimeline—Dysgeusia—Capecitabine—colon cancer	0.000691	0.000852	CcSEcCtD
Cevimeline—Photosensitivity reaction—Methotrexate—colon cancer	0.000688	0.000849	CcSEcCtD
Cevimeline—Back pain—Capecitabine—colon cancer	0.000682	0.000842	CcSEcCtD
Cevimeline—Abdominal pain—Irinotecan—colon cancer	0.00068	0.000839	CcSEcCtD
Cevimeline—Body temperature increased—Irinotecan—colon cancer	0.00068	0.000839	CcSEcCtD
Cevimeline—Feeling abnormal—Fluorouracil—colon cancer	0.000679	0.000838	CcSEcCtD
Cevimeline—Muscle spasms—Capecitabine—colon cancer	0.000678	0.000837	CcSEcCtD
Cevimeline—Pneumonia—Methotrexate—colon cancer	0.000676	0.000834	CcSEcCtD
Cevimeline—Depression—Methotrexate—colon cancer	0.00067	0.000827	CcSEcCtD
Cevimeline—Tremor—Capecitabine—colon cancer	0.000661	0.000816	CcSEcCtD
Cevimeline—Stomatitis—Methotrexate—colon cancer	0.000655	0.000808	CcSEcCtD
Cevimeline—Ill-defined disorder—Capecitabine—colon cancer	0.000654	0.000808	CcSEcCtD
Cevimeline—Urticaria—Fluorouracil—colon cancer	0.000654	0.000808	CcSEcCtD
Cevimeline—Conjunctivitis—Methotrexate—colon cancer	0.000653	0.000806	CcSEcCtD
Cevimeline—Anaemia—Capecitabine—colon cancer	0.000652	0.000805	CcSEcCtD
Cevimeline—Body temperature increased—Fluorouracil—colon cancer	0.000651	0.000804	CcSEcCtD
Cevimeline—Hypersensitivity—Vincristine—colon cancer	0.000651	0.000803	CcSEcCtD
Cevimeline—Haematuria—Methotrexate—colon cancer	0.000641	0.000791	CcSEcCtD
Cevimeline—Malaise—Capecitabine—colon cancer	0.000636	0.000785	CcSEcCtD
Cevimeline—Epistaxis—Methotrexate—colon cancer	0.000634	0.000782	CcSEcCtD
Cevimeline—Vertigo—Capecitabine—colon cancer	0.000634	0.000782	CcSEcCtD
Cevimeline—Hypersensitivity—Irinotecan—colon cancer	0.000634	0.000782	CcSEcCtD
Cevimeline—Asthenia—Vincristine—colon cancer	0.000634	0.000782	CcSEcCtD
Cevimeline—Syncope—Capecitabine—colon cancer	0.000633	0.000781	CcSEcCtD
Cevimeline—Leukopenia—Capecitabine—colon cancer	0.000631	0.000779	CcSEcCtD
Cevimeline—Agranulocytosis—Methotrexate—colon cancer	0.000627	0.000774	CcSEcCtD
Cevimeline—Palpitations—Capecitabine—colon cancer	0.000623	0.000769	CcSEcCtD
Cevimeline—Loss of consciousness—Capecitabine—colon cancer	0.00062	0.000765	CcSEcCtD
Cevimeline—Asthenia—Irinotecan—colon cancer	0.000617	0.000762	CcSEcCtD
Cevimeline—Cough—Capecitabine—colon cancer	0.000615	0.00076	CcSEcCtD
Cevimeline—Hypertension—Capecitabine—colon cancer	0.000609	0.000752	CcSEcCtD
Cevimeline—Hypersensitivity—Fluorouracil—colon cancer	0.000607	0.000749	CcSEcCtD
Cevimeline—Haemoglobin—Methotrexate—colon cancer	0.000606	0.000748	CcSEcCtD
Cevimeline—Diarrhoea—Vincristine—colon cancer	0.000604	0.000746	CcSEcCtD
Cevimeline—Haemorrhage—Methotrexate—colon cancer	0.000603	0.000744	CcSEcCtD
Cevimeline—Chest pain—Capecitabine—colon cancer	0.0006	0.000741	CcSEcCtD
Cevimeline—Myalgia—Capecitabine—colon cancer	0.0006	0.000741	CcSEcCtD
Cevimeline—Arthralgia—Capecitabine—colon cancer	0.0006	0.000741	CcSEcCtD
Cevimeline—Pharyngitis—Methotrexate—colon cancer	0.000599	0.000739	CcSEcCtD
Cevimeline—Anxiety—Capecitabine—colon cancer	0.000598	0.000739	CcSEcCtD
Cevimeline—Discomfort—Capecitabine—colon cancer	0.000593	0.000732	CcSEcCtD
Cevimeline—Urethral disorder—Methotrexate—colon cancer	0.000591	0.00073	CcSEcCtD
Cevimeline—Diarrhoea—Irinotecan—colon cancer	0.000588	0.000726	CcSEcCtD
Cevimeline—Dizziness—Vincristine—colon cancer	0.000584	0.000721	CcSEcCtD
Cevimeline—Pruritus—Fluorouracil—colon cancer	0.000583	0.000719	CcSEcCtD
Cevimeline—Visual impairment—Methotrexate—colon cancer	0.000581	0.000717	CcSEcCtD
Cevimeline—Confusional state—Capecitabine—colon cancer	0.00058	0.000716	CcSEcCtD
Cevimeline—Oedema—Capecitabine—colon cancer	0.000576	0.00071	CcSEcCtD
Cevimeline—Infection—Capecitabine—colon cancer	0.000572	0.000706	CcSEcCtD
Cevimeline—Dizziness—Irinotecan—colon cancer	0.000569	0.000702	CcSEcCtD
Cevimeline—Shock—Capecitabine—colon cancer	0.000566	0.000699	CcSEcCtD
Cevimeline—Nervous system disorder—Capecitabine—colon cancer	0.000565	0.000697	CcSEcCtD
Cevimeline—Eye disorder—Methotrexate—colon cancer	0.000564	0.000696	CcSEcCtD
Cevimeline—Diarrhoea—Fluorouracil—colon cancer	0.000564	0.000696	CcSEcCtD
Cevimeline—Thrombocytopenia—Capecitabine—colon cancer	0.000564	0.000696	CcSEcCtD
Cevimeline—Tinnitus—Methotrexate—colon cancer	0.000562	0.000694	CcSEcCtD
Cevimeline—Tachycardia—Capecitabine—colon cancer	0.000562	0.000693	CcSEcCtD
Cevimeline—Vomiting—Vincristine—colon cancer	0.000562	0.000693	CcSEcCtD
Cevimeline—Cardiac disorder—Methotrexate—colon cancer	0.00056	0.000691	CcSEcCtD
Cevimeline—Skin disorder—Capecitabine—colon cancer	0.000559	0.00069	CcSEcCtD
Cevimeline—Rash—Vincristine—colon cancer	0.000557	0.000687	CcSEcCtD
Cevimeline—Hyperhidrosis—Capecitabine—colon cancer	0.000556	0.000687	CcSEcCtD
Cevimeline—Dermatitis—Vincristine—colon cancer	0.000556	0.000687	CcSEcCtD
Cevimeline—Headache—Vincristine—colon cancer	0.000553	0.000683	CcSEcCtD
Cevimeline—Anorexia—Capecitabine—colon cancer	0.000549	0.000677	CcSEcCtD
Cevimeline—Angiopathy—Methotrexate—colon cancer	0.000547	0.000675	CcSEcCtD
Cevimeline—Vomiting—Irinotecan—colon cancer	0.000547	0.000675	CcSEcCtD
Cevimeline—Dizziness—Fluorouracil—colon cancer	0.000545	0.000672	CcSEcCtD
Cevimeline—Rash—Irinotecan—colon cancer	0.000542	0.000669	CcSEcCtD
Cevimeline—Dermatitis—Irinotecan—colon cancer	0.000542	0.000669	CcSEcCtD
Cevimeline—Chills—Methotrexate—colon cancer	0.000541	0.000668	CcSEcCtD
Cevimeline—Headache—Irinotecan—colon cancer	0.000539	0.000665	CcSEcCtD
Cevimeline—Hypotension—Capecitabine—colon cancer	0.000538	0.000664	CcSEcCtD
Cevimeline—Alopecia—Methotrexate—colon cancer	0.000533	0.000658	CcSEcCtD
Cevimeline—Malnutrition—Methotrexate—colon cancer	0.000525	0.000648	CcSEcCtD
Cevimeline—Nausea—Vincristine—colon cancer	0.000525	0.000647	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000524	0.000647	CcSEcCtD
Cevimeline—Vomiting—Fluorouracil—colon cancer	0.000524	0.000646	CcSEcCtD
Cevimeline—Insomnia—Capecitabine—colon cancer	0.000521	0.000643	CcSEcCtD
Cevimeline—Rash—Fluorouracil—colon cancer	0.000519	0.000641	CcSEcCtD
Cevimeline—Dermatitis—Fluorouracil—colon cancer	0.000519	0.00064	CcSEcCtD
Cevimeline—Paraesthesia—Capecitabine—colon cancer	0.000517	0.000638	CcSEcCtD
Cevimeline—Headache—Fluorouracil—colon cancer	0.000516	0.000637	CcSEcCtD
Cevimeline—Dysgeusia—Methotrexate—colon cancer	0.000514	0.000635	CcSEcCtD
Cevimeline—Dyspnoea—Capecitabine—colon cancer	0.000513	0.000633	CcSEcCtD
Cevimeline—Nausea—Irinotecan—colon cancer	0.000511	0.000631	CcSEcCtD
Cevimeline—Back pain—Methotrexate—colon cancer	0.000508	0.000627	CcSEcCtD
Cevimeline—Dyspepsia—Capecitabine—colon cancer	0.000507	0.000625	CcSEcCtD
Cevimeline—Decreased appetite—Capecitabine—colon cancer	0.0005	0.000618	CcSEcCtD
Cevimeline—Fatigue—Capecitabine—colon cancer	0.000496	0.000613	CcSEcCtD
Cevimeline—Constipation—Capecitabine—colon cancer	0.000492	0.000608	CcSEcCtD
Cevimeline—Pain—Capecitabine—colon cancer	0.000492	0.000608	CcSEcCtD
Cevimeline—Nausea—Fluorouracil—colon cancer	0.000489	0.000604	CcSEcCtD
Cevimeline—Ill-defined disorder—Methotrexate—colon cancer	0.000487	0.000601	CcSEcCtD
Cevimeline—Anaemia—Methotrexate—colon cancer	0.000485	0.000599	CcSEcCtD
Cevimeline—Feeling abnormal—Capecitabine—colon cancer	0.000474	0.000585	CcSEcCtD
Cevimeline—Malaise—Methotrexate—colon cancer	0.000474	0.000584	CcSEcCtD
Cevimeline—Vertigo—Methotrexate—colon cancer	0.000472	0.000582	CcSEcCtD
Cevimeline—Gastrointestinal pain—Capecitabine—colon cancer	0.000471	0.000581	CcSEcCtD
Cevimeline—Leukopenia—Methotrexate—colon cancer	0.00047	0.00058	CcSEcCtD
Cevimeline—Cough—Methotrexate—colon cancer	0.000458	0.000565	CcSEcCtD
Cevimeline—Urticaria—Capecitabine—colon cancer	0.000457	0.000564	CcSEcCtD
Cevimeline—Abdominal pain—Capecitabine—colon cancer	0.000455	0.000562	CcSEcCtD
Cevimeline—Body temperature increased—Capecitabine—colon cancer	0.000455	0.000562	CcSEcCtD
Cevimeline—Convulsion—Methotrexate—colon cancer	0.000455	0.000561	CcSEcCtD
Cevimeline—Arthralgia—Methotrexate—colon cancer	0.000447	0.000552	CcSEcCtD
Cevimeline—Chest pain—Methotrexate—colon cancer	0.000447	0.000552	CcSEcCtD
Cevimeline—Myalgia—Methotrexate—colon cancer	0.000447	0.000552	CcSEcCtD
Cevimeline—Discomfort—Methotrexate—colon cancer	0.000442	0.000545	CcSEcCtD
Cevimeline—Confusional state—Methotrexate—colon cancer	0.000432	0.000533	CcSEcCtD
Cevimeline—Infection—Methotrexate—colon cancer	0.000426	0.000525	CcSEcCtD
Cevimeline—Hypersensitivity—Capecitabine—colon cancer	0.000424	0.000523	CcSEcCtD
Cevimeline—Nervous system disorder—Methotrexate—colon cancer	0.00042	0.000519	CcSEcCtD
Cevimeline—Thrombocytopenia—Methotrexate—colon cancer	0.00042	0.000518	CcSEcCtD
Cevimeline—Skin disorder—Methotrexate—colon cancer	0.000416	0.000514	CcSEcCtD
Cevimeline—Hyperhidrosis—Methotrexate—colon cancer	0.000414	0.000511	CcSEcCtD
Cevimeline—Asthenia—Capecitabine—colon cancer	0.000413	0.00051	CcSEcCtD
Cevimeline—Anorexia—Methotrexate—colon cancer	0.000408	0.000504	CcSEcCtD
Cevimeline—Pruritus—Capecitabine—colon cancer	0.000407	0.000503	CcSEcCtD
Cevimeline—Hypotension—Methotrexate—colon cancer	0.0004	0.000494	CcSEcCtD
Cevimeline—Diarrhoea—Capecitabine—colon cancer	0.000394	0.000486	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Methotrexate—colon cancer	0.00039	0.000482	CcSEcCtD
Cevimeline—Insomnia—Methotrexate—colon cancer	0.000388	0.000478	CcSEcCtD
Cevimeline—Paraesthesia—Methotrexate—colon cancer	0.000385	0.000475	CcSEcCtD
Cevimeline—Dyspnoea—Methotrexate—colon cancer	0.000382	0.000472	CcSEcCtD
Cevimeline—Somnolence—Methotrexate—colon cancer	0.000381	0.00047	CcSEcCtD
Cevimeline—Dizziness—Capecitabine—colon cancer	0.000381	0.00047	CcSEcCtD
Cevimeline—Dyspepsia—Methotrexate—colon cancer	0.000377	0.000466	CcSEcCtD
Cevimeline—Decreased appetite—Methotrexate—colon cancer	0.000373	0.00046	CcSEcCtD
Cevimeline—Fatigue—Methotrexate—colon cancer	0.000369	0.000456	CcSEcCtD
Cevimeline—Pain—Methotrexate—colon cancer	0.000366	0.000452	CcSEcCtD
Cevimeline—Vomiting—Capecitabine—colon cancer	0.000366	0.000452	CcSEcCtD
Cevimeline—Rash—Capecitabine—colon cancer	0.000363	0.000448	CcSEcCtD
Cevimeline—Dermatitis—Capecitabine—colon cancer	0.000363	0.000448	CcSEcCtD
Cevimeline—Headache—Capecitabine—colon cancer	0.000361	0.000445	CcSEcCtD
Cevimeline—Feeling abnormal—Methotrexate—colon cancer	0.000353	0.000436	CcSEcCtD
Cevimeline—Gastrointestinal pain—Methotrexate—colon cancer	0.00035	0.000432	CcSEcCtD
Cevimeline—Nausea—Capecitabine—colon cancer	0.000342	0.000422	CcSEcCtD
Cevimeline—Urticaria—Methotrexate—colon cancer	0.00034	0.00042	CcSEcCtD
Cevimeline—Body temperature increased—Methotrexate—colon cancer	0.000339	0.000418	CcSEcCtD
Cevimeline—Abdominal pain—Methotrexate—colon cancer	0.000339	0.000418	CcSEcCtD
Cevimeline—Hypersensitivity—Methotrexate—colon cancer	0.000316	0.00039	CcSEcCtD
Cevimeline—Asthenia—Methotrexate—colon cancer	0.000307	0.000379	CcSEcCtD
Cevimeline—Pruritus—Methotrexate—colon cancer	0.000303	0.000374	CcSEcCtD
Cevimeline—Diarrhoea—Methotrexate—colon cancer	0.000293	0.000362	CcSEcCtD
Cevimeline—Dizziness—Methotrexate—colon cancer	0.000283	0.00035	CcSEcCtD
Cevimeline—Vomiting—Methotrexate—colon cancer	0.000272	0.000336	CcSEcCtD
Cevimeline—Rash—Methotrexate—colon cancer	0.00027	0.000333	CcSEcCtD
Cevimeline—Dermatitis—Methotrexate—colon cancer	0.00027	0.000333	CcSEcCtD
Cevimeline—Headache—Methotrexate—colon cancer	0.000268	0.000331	CcSEcCtD
Cevimeline—Nausea—Methotrexate—colon cancer	0.000255	0.000314	CcSEcCtD
